Animal study demonstrates high-intensity interval swimming restores hippocampal GDNF signaling in Parkinsonian rats, highlighting exercise-driven neuroprotection over gallic acid supplementation.
Objective Neurotrophic signaling is dysregulated in Parkinson’s disease (PD), while gallic acid possesses anti-inflammatory and potential neuroprotective properties. This study investigated the effects of high-intensity interval training (HIIT) swimming and gallic acid supplementation on the glial cell line-derived neurotrophic factor (GDNF) signaling pathway in a rat model of PD.Materials and methods Thirty-five male Wistar rats (8–10 weeks) were randomly assigned to five groups: healthy control, PD control, PD + HIIT swimming, PD + gallic acid, and PD + HIIT + gallic acid. PD was induced by reserpine (1 mg/kg/day, 5 days). Following induction, animals underwent six weeks of HIIT swimming (three sessions/week), while supplemented groups received gallic acid (200 mg/kg, three times/week). Gene expression levels of GDNF, RET proto-oncogene (RET), nuclear receptor-related 1 protein (NURR1), and microRNA-132 (miR-132) were assessed in hippocampal tissue.Results Reserpine significantly reduced GDNF (p = 0.003), RET (p = 0.03), and NURR1 (p = 0.04) expression and increased miR-132 expression (p = 0.002) compared with healthy controls. HIIT increased GDNF (p = 0.002), RET (p = 0.001), and NURR1 (p = 0.01) expression and decreased miR-132 expression (p = 0.04). Gallic acid significantly affected RET expression (p = 0.02), whereas its effects on GDNF (p = 0.05), NURR1 (p = 0.07), and miR-132 (p = 0.16) were not significant. No significant interaction was observed between HIIT and gallic acid for GDNF (p = 0.11), RET (p = 0.86), NURR1 (p = 0.08), or miR-132 (p = 0.83).Conclusion HIIT swimming effectively modulated components of the GDNF signaling pathway in this PD model, suggesting its neuroprotective potential. Gallic acid did not provide additional benefits under these conditions, and HIIT swimming showed broader effects than gallic acid.
No takes yet. Share an insight, caveat, or question.
Moghadasi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: